-
Professor Chen Yaokai: Factors Affecting the Prognosis of HIV Patients with Talaromyces Marneffei Co-Infection Treated with Amphotericin B Deoxycholate
Talaromyces marneffei (TM) is a thermal dimorphic fungus that can cause systemic fungal infections in humans. This fungal infection is common in immunocompromised individuals and is one of the leading causes of death among HIV/AIDS patients in Southeast Asia and South Asia. At the 19th European AIDS Conference (EACS) held from October 18 to 21,…
-
Professor Chen Yaokai: A Systematic Review and Meta-Analysis of Raltegravir Treatment for HIV-Positive Pregnant Women
HIV can be transmitted through bodily fluids such as blood, breast milk, semen, and vaginal secretions. Pregnant women who are infected with HIV should receive antiretroviral therapy (ART) as soon as possible to protect their own health and reduce the risk of transmitting HIV to their unborn child. At the recent 19th European AIDS Conference…
-
Professor Zhu Biao: Impact of Single-Tablet HIV Medications B/F/TAF and E/C/F/TAF on Lipid Metabolism
AIDS remains a significant global health concern, but recent advancements in medical technology have shifted the treatment of HIV-infected individuals toward a chronic disease management approach. Ensuring treatment safety and adherence is a critical challenge within this context. Currently, two single-tablet regimens, Biktarvy (B/F/TAF) and Descovy (E/C/F/TAF), are widely used globally, including in China, for…
-
Professor Lv Wei: An All-Encompassing Interpretation of Clinical Diagnosis and Treatment Strategies for Late-Diagnosed HIV Patients
This article features an interview with Professor Lv Wei, offering a comprehensive analysis of the clinical diagnosis and treatment strategies for late-presenting HIV patients. This group is a significant challenge in China’s HIV/AIDS prevention and treatment efforts due to their higher hospitalization and transmission rates, heavier economic burdens, and poorer long-term prognosis.
-
Pay attention to the comorbidities of the heart, lungs, and metabolic system in HIV infected individuals
Anti retroviral therapy (ART) significantly improves the life expectancy of HIV infected individuals. However, in recent years, the incidence rate of cardiovascular diseases and other complications related to obesity, type 2 diabetes, and metabolic syndrome (namely, abdominal obesity, hypertension, elevated triglyceride levels, dyslipidemia, and changes in blood glucose levels) has gradually increased among HIV infected…
-
Exposure and Response to ART Drugs in Obese HIV-Infected Individuals
This article is an interview transcript from the 19th European AIDS Conference (EACS 2023) featuring Dr. Mattia Berton from the University Hospital Basel, Switzerland. The focus of the interview is on the study of antiretroviral therapy (ART) drug exposure and response in obese HIV-infected individuals.
-
CVD risks in women living with HIV
Hi there. My name is Chris Longenecker. I’m a cardiologist at the University of Washington in Seattle, Washington, USA. I specialize in the care of people living with HIV infection. For many years I’ve run a clinic focused on cardiovascular disease management and prevention of cardiovascular disease for people living with HIV, first in Cleveland,…
-
Advances and Challenges in the Use of Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) for HIV
With continuous progress in HIV treatment, the mortality rate has significantly decreased, and new infections have stabilized. However, there is still a gap from the 2020 targets set by the United Nations Programme on HIV/AIDS. To control new HIV infections, a comprehensive use of behavioral and biomedical methods, including antiviral drugs for pre-exposure prophylaxis (PrEP)…
Connecting Medical Expertise through Media